EGFR-HER2 inhibitor CNX-2006, Purity ≥98%

Cat. No.: X24-05-ZQ643

EGFR-HER2 inhibitor CNX-2006, Purity ≥98%

Synonym: 1375465-09-0; CNX2006; CNX 2006; EGFR-HER2 inhibitor

  • CAS Number: 1375465-09-0
  • Compound CID: 56968072
Product Size
10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
CNX-2006, soluble in DMSO and ethanol and insoluble in water, is a compound that blocks the activity of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2), both of which are involved in driving the growth and proliferation of certain types of cancer cells. It targets EGFR(L858R/T790M).
Molecular Weight
545.53
Molecular Formula
C26H27F4N7O2
Targets
EGFR(L858R/T790M): 20 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 90 mg/mL (164.97 mM); Water: Insoluble; Ethanol: 26 mg/mL (47.65 mM)
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
CNX-2006 is applied to research its selective inhibition of EGFR mutants, contributing to studies on targeted cancer therapies.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.